Endocyte (ECYT) Tops Q3 EPS by 3c

Endocyte (NASDAQ: ECYT) reported Q3 EPS of ($0.24), $0.03 better than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Endocyte (ECYT) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Amtech Systems closes $60 million public stock offering
• Morgan Stanley lifts MU and SNDK targets, sees 2-3 years of tight memory supply